Navigation Links
Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
Date:12/8/2008

- Fluoroquinolone Compound Demonstrates Potent Activity Against Antibiotic Resistant Gram-Positive Pathogens and MRSA in Skin Infections -

NEW HAVEN, Conn., Dec. 8 /PRNewswire-FirstCall/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery, development and commercialization of novel antibiotics for the treatment of antibiotic-resistant infections, today announced positive topline results from a Phase 2 clinical trial with the intravenous form of its novel anionic quinolone antibiotic, delafloxacin (RX-3341). The double-blind study showed that both doses (300mg BID and 450mg BID) of delafloxacin were as efficacious as the FDA approved dosing regime for tigecycline in the treatment of complicated skin and skin structure infections (cSSSI). Additionally, when evaluated in vitro against the Gram-positive and Gram-negative organisms isolated from patients within this trial, delafloxacin was shown to be the more active compound overall, including its activity against Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) and quinolone-resistant Gram-positive pathogens.

"This is the third Phase 2 clinical trial showing delafloxacin to be both efficacious and safe," said Susan Froshauer, PhD, President and CEO of Rib-X Pharmaceuticals. "The data for delafloxacin continues to show that this broad spectrum compound is likely to be a valuable tool in the armamentarium of agents for treatment of resistant bacterial infections. In fact, delafloxacin has been shown to be extremely effective against resistant Gram-positive bacteria, including MRSA. While we look forward to a complete review of the final data and in particular the subset data, we are encouraged by these results and the two previous Phase 2 studies, and we will continue to focus on the development of this potent antibiotic."

The Company is developing both the oral and
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
2. Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council
3. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
4. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
5. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...RD,Mass.,Nov.25/PRNewswire-FirstCall/--Hologic,Inc...loper,manufacturerandsupplierofpremiumdiagnostics,...oservingthehealthcareneedsofwomen,isusingtheannual...)atMcCormickPlaceinChicago,November29throughDecemb...odalitydiagnosticmammographyworkstationsoftware. ,...
(Date:11/25/2009)...,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGroup,In... report,thefirstinamulti-phasesyndicatedmarketres...ch,sStelara,fromproductlaunchthroughthefirstsixmon...itativeinformationfrom75uniqueDermatologistsandqua...strialanduseofStelara,obstaclestouse,typicalpatien...
(Date:11/25/2009)...OCORDOVA,Calif.,Nov.25/PRNewswire/--AMPACFineChemi...on(Nasdaq: APFC )announcedtodaythatitreceivedtheEn...heAnnualStatewideEnvironmentalSummit,sponsoredbyth...MTA),theIndustrialEnvironmentalAssociation(IEA)and...SanDiego.Thisisthemostprestigiousawardavailablefro...
Breaking Medicine Technology:New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Study of DuraPrep versus chlorhexidine 59252 1Study of DuraPrep versus chlorhexidine 59252 2New lab on a chip technique developed at U of T 14419 1New lab on a chip technique developed at U of T 14419 2Panama butterfly migrations linked to El Nio climate change 10315 1Panama butterfly migrations linked to El Nio climate change 10315 2
...Collaboration with Lentigen Expands Research Appli... Fisher,Scientific Inc. (NYSE: TMO ), the world l...ntigen Corporation to develop a powerful new techn...(RNA interference) to critical,fields of life scie...and,stem cell biology. This advancement, called Th...
...3,000 Patient Multi-center IVUS Sub-study Part of ...S Study to Quantify Causes and Cures of Drug ...IEGO, Oct. 22 Volcano Corporation,(Nasdaq: VOLC ...r of,intravascular ultrasound (IVUS) and functiona...sponsorship of the first major study designed to,e...
Other Medicine Technology:Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research 2Thermo Fisher Scientific Advances Gene-Silencing Technology for Life Sciences Research 3Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 2Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 3Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome 4
(Date:11/27/2009)... Multi-purpose bilingual coloring books...use by the business community to educate - inform ...s from Safety issues to Dinosuars to ABC,S and a h...int Louis, MO (PRWEB) November 27, 2009 -- Today&r...r toys to keep them busy any hour of the day, but ...
(Date:11/27/2009)... Three new interactive anatomy educatio... Wilkins expand health sciences learning opportuni... Durham, NC (Vocus) November 27, 2009 -- M...ns (LWW), a division of Wolters Kluwer Health, tod... education apps on the App Store. Clemente’s...
(Date:11/26/2009)...TON,N.J.,Nov.27/PRNewswire/--Thediabetespopulation...sandannualmedicalspendingonthediseaseisprojectedto...studypublishedintheDecemberissueof DiabetesCare .T...rogramofNovoNordisk,commissionedtheanalysisbyateam...recast,thenumberofAmericanslivingwithdiabeteswillr...
(Date:11/26/2009)...equestering drug tetrathiomolybdate (TM) has been ...of Wilson disease, a disease caused by an overload...uch is known. Very little, however, is known about...new study led by Northwestern University researche...dimensional structure of TM bound to copper-loaded...
(Date:11/26/2009)...ger thrill when on an emotional rollercoaster, stu...y News) -- Call it the fear factor meets the jubil...ctators -- especially those who root for the winni... a closely contested match and victory was in doub..., Chew on that this Thanksgiving weekend as you,...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
...y "Childhood Asthma Management Program" (CAMP) has...ctive for the long-term treatment of children with... around the world have recognized the effectivenes...le effects on growth," said Dr. Claude Lenfant. "C...
...ten difficult to diagnose and many a times the dia...n reaction (PCR) is emerging as a promising techni...he technique involves detection of bacteria by fac...Presence of even one bacteria can be detected by t...
... men over the age of 40 years and is the second co...y it goes undetected till it is advanced and beyon...d about this condition and now men over the age of...to detect prostate cancer and is called "Prostate ...
...ement therapy (HRT) does not reduce the risk of ...ng coronary artery disease (CAD). In the PHASE t...rchers randomized 255 postmenopausal women with ...hormone replacement therapy. The women were follow...
...the Prime Minister of India has successfully under...an Ranawat at the Breach Candy Hospital in Mumbai....was completed by 11.15 a.m. and went on very well,...ecovery room. He is not on any sedative. I talked ...
...ime have found a way for the survival of endangere...through a Massachusetts scientists who engineered...gered animal (Asian Gaur) and successfully impregn...e cloned Asian gaur sometime next month. The Asia...
Other Medicine News:Health News:Inhaled Steroids Safe & Effective for Children with Asthma 2
Sonotom 110 with probe 15 angled
... is intended for destruction and removal of pathol...erventions in the field of a cerebrum brain, spina...ne in a consequence of a working tip making ultras...n arises cavitational processes. They promote dest...
Dissectron Ultrasonic Aspirator
Sugita Aneurysm Clip L-Shaped Angled To L(M)
Medicine Products: